scispace - formally typeset
Open AccessJournal Article

Establishment and characterization of a human prostatic carcinoma cell line (PC-3).

M E Kaighn, +4 more
- 01 Jul 1979 - 
- Vol. 17, Iss: 1, pp 16-23
TLDR
The establishment, characterization, and tumorigenicity of a new epithelial cell line (PC-3) from a human prostatic adenocarcinoma metastatic to bone is reported, which should be useful in investigating the biochemical changes in advanced prostatic cancer cells and in assessing their response to chemotherapeutic agents.
Abstract
The establishment, characterization, and tumorigenicity of a new epithelial cell line (PC-3) from a human prostatic adenocarcinoma metastatic to bone is reported The cultured cells show anchorage-independent growth in both monolayers and in soft agar suspension and produce subcutaneous tumors in nude mice Culture of the transplanted tumor yielded a human cell line with characteristics identical to those used initially to produce the tumor PC-3 has a greatly reduced dependence upon serum for growth when compared to normal prostatic epithelial cells and does not respond to androgens, glucocorticoids, or epidermal or fibroblast gowth factors Karyotypic analysis by quinacrine banding revealed the cells to be completely aneuploid with a modal chromosome number in the hypotriploid range At least 10 distinctive marker chromosomes were identified The overall karyotype as well as the marker chromosomes are distinct from those of the HeLa cell Electron microscopic studies revealed many features common to neoplastic cells of epithelial origin including numerous microvilli, junctional complexes, abnormal nuclei and nucleoli, abnormal mitochondria, annulate lamellae, and lipoidal bodies Overall, the functional and morphologic characteristics of PC-3 are those of a poorly-differentiated adenocarcinoma These cells should be useful in investigating the biochemical changes in advanced prostatic cancer cells and in assessing their response to chemotherapeutic agents

read more

Citations
More filters
Journal ArticleDOI

Rh2 or its aglycone aPPD in combination with docetaxel for treatment of prostate cancer

TL;DR: This study assesses the combination of well tolerated and orally bioavailable formulations of ginsenoside Rh2 or its aglycone aPPD with docetaxel for prostate cancer patients that have relapsed and/or metastatic disease.
Journal ArticleDOI

The effects of brefeldin A (BFA) on cell cycle progression involving the modulation of the retinoblastoma protein (pRB) in PC-3 prostate cancer cells.

TL;DR: Results suggest that BFA may be a potent cell cycle modulator, which post-translationally regulates pRB phosphorylation possibly by down-regulating cdk2, cdk4, and cyclin D1 and/or by up- Regulating a phosphatase(s) capable of dephosphorylating pRB.
Journal ArticleDOI

Angiotropism of human prostate cancer cells: implications for extravascular migratory metastasis

TL;DR: To report several samples of invasive human prostate cancer showing angiotropism, and to use human prostatecancer cells stably expressing green fluorescence protein (GFP) in in vitro and in vivo models to assess the dissemination pathway of prostate cancer cells.
Journal ArticleDOI

A genetic screen in Drosophila for regulators of human prostate cancer progression.

TL;DR: These findings suggest that the development of the Drosophila accessory gland and human prostate cancer cell growth and invasion are partly regulated through a common mechanism.
Journal ArticleDOI

Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer

TL;DR: In vivo differences in CTC generation, kinetics, metastasis and EMT status were determined using 4 PCa models with progressive epithelial to mesenchymal (PC-3, PC-3M) phenotypes, and assay validation demonstrated that the CellSearch®-based assay failed to detect a significant number of mesenchyal CTCs.
Related Papers (5)